Global Active Pharmaceutical Ingredients (API) Market to Reach US$ 357.0 Billion by 2032, Impelled by Emerging Pharmaceutical Industry

April 26, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Active Pharmaceutical Ingredients (API) Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients (API), Generic Active Pharmaceutical Ingredients (API)), Type of Manufacturer (Captive Manufacturers, Merchant API Manufacturers), Type of Synthesis (Synthetic Active Pharmaceutical Ingredients (API), Biotech Active Pharmaceutical Ingredients (API)), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2024-2032," the global active pharmaceutical ingredients (API) market size reached US$ 234.7 Billion in 2023. Active pharmaceutical ingredients (API) refer to the biological component of a prescription or an over-the-counter (OTC) medication. This biologically active element represents the primary ingredient of numerous types of pharmaceutical drugs that produce its intended health effects. Besides this, it also helps healthcare providers to recognize the distinction between generics and brand name versions in order to avoid accidental overdoses and harmful interactions. Some of the popular APIs include amoxicillin, metformin, levothyroxine, atorvastatin, gabapentin, amlodipine, fluoxetine and albuterol. With the rising demand for effective treatments and pharmaceutical drugs among the masses, there has been a considerable increase in the overall API market across the globe. 

Global Active Pharmaceutical Ingredients (API) Market Trends:

The global market is primarily driven by significant growth in the pharmaceutical industry. Coupled with the growing prevalence of numerous chronic illnesses, this is significantly supporting the demand for APIs across the globe. Apart from this, extensive research and development (R&D) activities conducted by key players to introduce improved product variants, such as highly potent active pharmaceutical ingredients, are creating a positive market outlook. The rapid advancements in the pharmaceutical industry during the pandemic have also provided an impetus to the active pharmaceutical ingredients market on the global level. Moreover, continual technological advancements in the field of biotechnology and life science are impacting the market favorably. Furthermore, the escalating number of research centers and scientific laboratories and the rising number of clinical trials are considered to be major growth-inducing factors. Other factors, including rapid urbanization, the increasing geriatric population and heavy spending by public and private agencies for upgrading the overall healthcare infrastructure, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 357.0 Billion by 2032, exhibiting a CAGR of 4.6% during 2024-2032.

Market Summary:

  • On the basis of the drug type, the market has been segmented into innovative active pharmaceutical ingredients (API) and generic active pharmaceutical ingredients (API).
  • Based on the type of manufacturer, the market has been bifurcated into captive manufacturers and merchant API manufacturers (innovative merchant API and manufacturers and generic merchant API manufacturers).
  • On the basis of the type of synthesis, the market has been categorized into synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
  • Based on the therapeutic application, the market has been segmented into oncology, cardiovascular and respiratory, diabetes, central nervous system disorders, neurological disorders and others.
  • On the basis of the region, the market has been divided into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America, and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia
Companies Covered Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Active Pharmaceutical Ingredients (API) Market to Reach US$ 357.0 Billion by 2032, Impelled by Emerging Pharmaceutical Industry
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More